Presentation is loading. Please wait.

Presentation is loading. Please wait.

Funding for Innovation Sue Dunkerton, HealthTech and Medicines KTN 11 December 2012.

Similar presentations

Presentation on theme: "Funding for Innovation Sue Dunkerton, HealthTech and Medicines KTN 11 December 2012."— Presentation transcript:

1 Funding for Innovation Sue Dunkerton, HealthTech and Medicines KTN 11 December 2012

2 Building a Healthy Nation through Business Innovation The HealthTech and Medicines KTN (Health KTN) supports business innovations through partnerships, access to funding and knowledge transfer Bringing together & facilitating collaborations with a common goal Connecting Partners Identify and influence new and existing sources of funding Access to Funding Opening doors to wider networks of people/organisations Knowledge Transfer

3 Clinical Needs Stratified Medicine Detection and Identification of Infectious Agents Regenerative Medicine Assisted Living Health KTN Priority Areas Novel Therapies Emerging Medical Technologies Synthetic Biology High Value Manufacturing

4 1 2 3 4 5 6 7 8 9 Research Councils- Responsive Mode Research, KTA TSB National & MRC- Biomedical Catalyst Research Councils- Case Awards, Industrial Case Awards, CDTs Europe- Networks of Excellence DH/NIHR- i4i Research Councils- Managed programmes, IKC’s Devolved Administration/ Regional Funding- Regional Growth Funds, Smart: Scotland Europe- AAL Europe- Framework 7 cooperation Health/NMP/ICT, Research For SMEs, AAL DoH/NIHR- Health Innovation Challenge Fund Devolved Administration/Regional Funding- R&D Grant Scotland, Welsh Government TSB National-Innovation Platforms, Collaborative R&D, Catapults, Biomedical Catalyst TSB National- Grant for R&D, Biomedical Catalyst, SMART, Innovation Vouchers Europe-PPP’s, Research for SMEs, Eureka/Eurostars TSB National- SBRI, KTP, Biomedical Catalyst Devolved Administration/Regional Funding- Manufacturing Advisor Service (MAS) Technology Readiness Level (TRL) 1-3 Basic Research 4-6 Applied Research 7-9 Commercialisation 1-3 Basic Research 4-6 Applied Research 7-9 Commercialisation Finance For Innovation Technology Readiness Level for Finance for Innovation in the UK and Europe. Businesses Business Angels Venture Capitalists Private Investors Useful websites for more information: Technology Strategy Board (TSB) National Europe Devolved Administration-,, DH/NIHR Research Councils

5 The Technology Strategy Board is to invest up to £10m in fast- track and collaborative research and development projects that stimulate innovation across the key enabling technology areas of advanced materials, biosciences, electronics, sensors and photonics and information and communications technology Competition is now open and deadline for registering express of interest is 23 rd January 2013 Technology Strategy Board Technology – Inspired Innovation Funding call

6 DH and NIHR funding i4i Product Development Award – 100% funding, England and Wales only i4i Challenge Award – 100% funding, lead applicant must be in England Health Innovation Challenge Fund – 2 themed calls a year (UK wide, with Wellcome Trust) Healthcare Technology Cooperatives - Provide an excellent route into the NHS for selected areas of unmet need 2 pilots, 6-8 launching 2013 (based in English Trust, open to national and international businesses)

7 Devolved Administrations and European Funding Devolved Administrations : Welsh Assembly Government (WAG) – £100m Welsh Life Sciences Fund Scotland – SMART: SCOTLAND – Research and Development Grant – Proof of Concept Fund Eurostars – Supports UK SMEs EU Framework Programme FP7 – Topics: Health, NMP, ICT, IMI (JTI) Horizon 2020 Ambient Assisted Living

8 UK Government UKTI – Passport to Export – Export Marketing Research Scheme – Overseas Market Introduction Service – Gateway to Global Growth – UKTI Venture Capital Team £300m Enterprise Capital Funds (ECF) programme UK Innovation Investment Fund —UK Future Technologies Fund (UKFTF) £50m Business Angel co- investment Fund Fiscal Measure R&D tax credit for SMEs – increased the level of super- deduction relief available to 225% – no minimum spend requirement Patent Box – 10% rate of corporation tax on profits from patents/IP – applies worldwide to existing and new IP 24% Corporate Tax Rate

9 KTN Support incl. Support Map Innovation Support Map Accessing Clinical Needs Selling to the NHS Complying with Regulations Accessing Funding Accessing Research Capabilities Accessing Market Information Accessing Business Support Accessing Networks

Download ppt "Funding for Innovation Sue Dunkerton, HealthTech and Medicines KTN 11 December 2012."

Similar presentations

Ads by Google